Achieving success in a changing pharmaceutical landscape
The pharma and biopharma industry is experiencing a period of remarkable growth, with further expansion on the horizon. This presents exciting opportunities but also introduces new complexities in an already intricate landscape. To gain a deeper understanding of this evolving landscape, Alloga and ICS, Cencora’s third-party logistics (3PL) businesses, commissioned research involving a global survey of 250 senior decision-makers. This research looks into the future trends, potential challenges, and the critical role of 3PL partners in navigating the industry’s complexities.
This white paper explores key insights from this research to showcase how 3PL partnerships can help companies achieve their growth objectives in this fluid environment.
Download the white paper to learn more:
- 3PL partnerships in the pharma and biopharma landscape
- Growth outlook and associated challenges
- The growing importance of 3PL partnerships
- Key challenges and opportunities within pharma
- Seizing opportunities: Innovation and expansion through strategic 3PL partnerships
- Alloga and ICS: Empowering growth
- Case study: ICS expedites market entry with foreign trade zone (FTZ)
- Strategic partnerships for mutually assured success
